UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:	June 19, 2019 4:00 P.M.

Form:	S-1
CIK: 0001744659 Company Name: Akero Therapeutics, Inc. File Number: 333-231747